Información del producto
- (5S,6Z,8E,10E,12R,14Z)-5,12,20-Trihydroxy-6,8,10,14-eicosatetraenoic acid
- (5S,6Z,8E,10E,12R,14Z)-5,12,20-trihydroxyicosa-6,8,10,14-tetraenoic acid
- 20-Hydroxy-LTB<sub>4</sub>
- 20-Hydroxyleukotriene B<sub>4</sub>
- 6,8,10,14-Eicosatetraenoic acid, 5,12,20-trihydroxy-, (5S,6Z,8E,10E,12R,14Z)-
- 6,8,10,14-Eicosatetraenoic acid, 5,12,20-trihydroxy-, [S-[R*,S*-(E,Z,E,Z)]]-
- ω-Hydroxy-LTB<sub>4</sub>
20-OH-LTB4 is a medicinal compound with potential anticancer properties. It has been shown to induce apoptosis in human and Chinese hamster ovary cells, making it a promising candidate for cancer treatment. 20-OH-LTB4 also inhibits the cell cycle by targeting kinases and other proteins involved in cancer cell growth. This compound has been identified as a potent inhibitor of urine-derived protein kinase, which plays a key role in cancer progression. In addition to its potential as an anticancer agent, 20-OH-LTB4 may have broader applications as a general inhibitor of kinases and other enzymes involved in cellular signaling pathways.
Propiedades químicas
Consulta técnica sobre: 3D-EDA51682 20-OH-LTB4
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
